Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 9, 2023
Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution ExperienceG Macchia, D Pezzulla, S Cilla, et al.
Annals of Surgical Oncology|November 9, 2020
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score AnalysisG Ferrandina, V Gallotta, A Federico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinomaC Lavarino, S Pilotti, M Oggionni, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 10, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, F Moro, T Pasciuto, et al.
The British Journal of Radiology|February 17, 2012
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful?M Massaccesi, C Digesù, G Macchia, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 17, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, G Ferrandina, F Moro, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 20, 2009
Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid componentsA C Testa, D Timmerman, V Van Belle, et al.
Gynecologic Oncology|November 4, 2019
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trialD Lorusso, G Ferrandina, N Colombo, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 9, 2023
Stereotactic Body Reirradiation in Gynaecological Cancer: Outcomes and Toxicities from a Single Institution ExperienceG Macchia, D Pezzulla, S Cilla, et al.
Annals of Surgical Oncology|November 9, 2020
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score AnalysisG Ferrandina, V Gallotta, A Federico, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinomaC Lavarino, S Pilotti, M Oggionni, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 10, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, F Moro, T Pasciuto, et al.
The British Journal of Radiology|February 17, 2012
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful?M Massaccesi, C Digesù, G Macchia, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trialD Lorusso, G Scambia, S Pignata, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|June 17, 2017
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgeryA C Testa, G Ferrandina, F Moro, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 20, 2009
Intravenous contrast ultrasound examination using contrast-tuned imaging (CnTI) and the contrast medium SonoVue for discrimination between benign and malignant adnexal masses with solid componentsA C Testa, D Timmerman, V Van Belle, et al.
Gynecologic Oncology|November 4, 2019
Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trialD Lorusso, G Ferrandina, N Colombo, et al.
Pageof 18